Save time and get answers to complex questions with AI chat
How many years does kadcyla's market exclusivity last?Guselkumab patent expiration?Does lipitor's effectiveness decrease with high fat meals?Defense strategy against generic in niche market?Combivent inhaler hfc 152a patents?
See the DrugPatentWatch profile for Dayvigo
Dayvigo (lemborexant) was approved by the FDA on December 18, 2019 for the treatment of insomnia in adults. Would you like the FDA press release or more details about indications, dosing, or safety?
Other Questions About Dayvigo :